What are you looking for? Search Common searches: Intranet, Contact, Map, Professionals, Teaching units, Research groups, Fulltext search Tipus de contingut Professionals Projects Teaching Units Collaborating entities News Activities - Any - Search News Vall d'Hebron begins two clinical trials to test a new system to filter blood and improve the evolution of COVID-19 and sepsis Seraph 100 consists of a filter capable of binding and eliminating microorganisms in the blood of patients who have an infection. The clinical trials that are now underway will study whether this system can reduce the severity of critical patients with COVID-19 and sepsis. News Dr. Joan Comella is appointed treasurer of ICORD and Dr. Mireia del Toro joins the board International Conference of Rare Diseases and Orphan Drugs (ICORD) is a world reference organization in rare diseases. News Vall d'Hebron participates in a study that identifies 33 new genetic variants associated with bipolar disorder These findings open the way for research into new therapeutic targets, as well as for the study of the possibility of reusing drugs that are already used in other illnesses for the treatment of bipolar disorder. News Vall d’Hebron identifies memory immune cells in blood and lungs essential for the control of SARS-CoV-2 Researchers have found lung-resident memory T lymphocytes months after SARS-CoV-2 infection, which would rapidly activate in the event of possible reinfection. News Vall d’Hebron has reached a record number of clinical trials despite the pandemic 2020 ended with the highest number of clinical trials recorded at the Vall d’Hebron Campus, which includes the Vall d'Hebron Research Institute (VHIR) and the Vall d'Hebron Institute of Oncology (VHIO): 1,365 active and 319 new. News Vall d’Hebron begins the clinical trial in pregnant women of the Pfizer and BioNTech vaccine against COVID-19 The study will evaluate the safety, immunogenicity and efficacy of the vaccine in pregnant women, the passive transfer of antibodies to the fetus and the protection conferred during lactation. News A work led by Vall d'Hebron demonstrates the relationship between immune-mediated inflammatory diseases and changes in diet The study, carried out with more than 11,000 patients, aims to understand the effect of food on these diseases to give recommendations based on evidence. News Vall d’Hebron assumes the rotating presidency of the European University Hospital Alliance (EUHA) Dr. Albert Salazar, manager of Vall d'Hebron University Hospital, assumes for the next six months the presidency of the European University Hospital Alliance (EUHA), an alliance formed by the largest university hospitals in Europe working in collaboration to improve the outcomes of patients from News Vall d'Hebron is the center with the most projects promoted by La Marató de 2020 to research on Covid-19 There are 6 coordinated projects, led by Vall d'Hebron Research Institute (VHIR) researchers Maria José Buzón, Meritxell Genescà, Maria José Soler, Matilde Lleonart and Antonio Soriano; and, by the Vall d'Hebron Oncology Institute (VHIO), Paolo Nuciforo. We must also add the participation of prof News Endolipid Therapeutics, the spin-off of Vall d’Hebron and GENESIS Ventures, emerges to develop a new strategy to reduce visceral and subcutaneous fat Endolipid Therapeutics has developed a new approach to reducing visceral fat with therapeutic applications to treat, for example, fatty liver, and applications will be developed to reduce subcutaneous fat. Pagination Previous page ‹‹ Page 55 Next page ››